Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004054514 | SCV002663257 | uncertain significance | not specified | 2023-12-22 | criteria provided, single submitter | clinical testing | The p.D222Y variant (also known as c.664G>T), located in coding exon 3 of the GALNT12 gene, results from a G to T substitution at nucleotide position 664. The aspartic acid at codon 222 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |